Register Login

MEDICINOVA INC (MNOV)

SymbolMNOV
NameMEDICINOVA INC
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address4275 EXECUTIVE SQUARE, LA JOLLA, CA 92037
Telephone858-373-1500
Fax—
Email—
Websitehttps://www.medicinova.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001226616
Description

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firms current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.

Additional info from NASDAQ:
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firms current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.

2026-04-29 17:34

New Form ARS - MEDICINOVA INC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001193125-26-191932 <b>Size:</b> 724 KB

Read more
2026-04-29 17:27

New Form DEF 14A - MEDICINOVA INC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001193125-26-191866 <b>Size:</b> 2 MB

Read more
2026-04-27 23:00

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

Read more
2026-04-20 18:03

New Form PRER14A - MEDICINOVA INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001193125-26-164217 <b>Size:</b> 2 MB

Read more
2026-04-17 17:57

New Form PRE 14A - MEDICINOVA INC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001193125-26-161734 <b>Size:</b> 1 MB

Read more
2026-03-16 11:00

MediciNova to Participate at the 38th Annual ROTH Conference

Read more
2026-03-10 18:18

New Form 10-K - MEDICINOVA INC <b>Filed:</b> 2026-03-10 <b>AccNo:</b> 0001193125-26-100432 <b>Size:</b> 9 MB

Read more
2026-02-20 11:25

(30% Negative) MEDICINOVA INC (MNOV) Reports Q1 2026 Financial Results

Read more
2026-01-29 23:00

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients

Read more
2026-01-20 22:04

Matsuda Kazuko 🟢 acquired 350.0K shares (1 derivative) of MEDICINOVA INC (MNOV) at $2.10 Transaction Date: Jan 16, 2026 | Filing ID: 000430

Read more